Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bophelo Bioscience is a Lesotho-based biotechnology company specializing in the large-scale cultivation, extraction, and distribution of medical-grade cannabis and hemp products. Operating one of the world's largest cannabis cultivation sites, the company leverages Lesotho's favorable high-altitude climate and regulatory environment to produce high-quality GACP and GMP-certified medicinal cannabis. Bophelo serves as a primary production and processing hub for its parent company, Akanda Corp, focusing on supplying international pharmaceutical markets, particularly in Europe and the United Kingdom. The company's operations include advanced greenhouse cultivation and extraction facilities designed to meet rigorous global standards for cannabinoid-based therapeutics. By integrating agricultural expertise with biotechnological processing, Bophelo aims to provide consistent, medical-grade cannabis flower and oils for a variety of therapeutic indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bophelo Bioscience.